Nodular lymphocyte predominance Hodgkin's disease: Long-term observation reveals a continuous pattern of recurrence

Leukemia and Lymphoma

Volumn 26, Issue 3-4, 1997, Pages 359-368

  Orlandi, Ester ^a,b   Lazzarino, Mario ^a,b   Brusamolino, Ercole ^a,b   Paulli, Marco ^c   Astori, Cesare ^a,b   Magrini, Umberto ^c   Bernasconi, Carlo ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Institute of Hematology   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Late recurrences; Long term observations; Nodular lymphocyte predominance Hodgkin's disease

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE HYPERPLASIA; LYMPHOCYTE; MALE; MULTIMODALITY CANCER THERAPY; NODULAR LYMPHOMATOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0030761139     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709051786     Document Type: Article

References (48)

1. Lukes, R J., Butler, J. J. and Hicks, E. B. (1966). Natural history of Hodgkin's disease as related to its pathologic picture. Cancer, 19, 317-324.
2. Colby, T V., Hoppe, R. T. and Warnke, R. A. (1981). Hodgkin's disease: A clinicopathologic study of 659 cases. Cancer. 49, 1848-58.
3. Mauch, P. M., Kalish, L. A., Kadin, M. C., Coleman, C. N., Osteen, R. and Hellman, S. (1993). Patterns of presentation of Hodgkin's disease: implications for etiology and pathogenesis. Cancer. 71, 2062-2071.
4. Pinkus, G. and Said, J. (1988). Hodgkin's Disease, Lymphocyte Predominance type. Further evidence for a B-cell derivation: L&H variants of Reed-Stemberg cells express L26, a pan B-cell marker. American Journal of Pathology, 133, 211-17.
5. Poppema, S. (1992). Lymphocyte-Predominance Hodgkin's Disease. Seminars Diagnostic Pathology, 9, 257-64.
6. Mason, D. Y., Banks, P. M., Chan, J., Clearly, M. L., Delsol, G., deWolf. P., et al. (1994). Nodular Lymphocyte Predominance Hodgkin's Disease: A distinct clinicopathological entity. American Journal of Surgical Pathology, 18, 526-30.
7. Harris, N. L., Stein, H., Banks, P. M., et al. (1994) A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood. 84, 1361-1392
8. Krikorian, J. G., Burke, J S and Rosenberg, S. A. (1979). Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. New England Journal of Medicine. 300, 452-58.
9. Armitage, J O., Dick, F. R and Groeken, J. A. (1983). Second lymphoid malignant neoplasm occurring in patients treated for Hodgkin's disease. Archives of Internal Medicine, 14, 445-50.
10. Miettinen, M., Fransilla, K. A. and Saxen, E. (1983). Hodgkin's disease, Lymphocytic Predominance Nodular. Increased risk for subsequent Non-Hodgkin's Lymphomas. Cancer, 51, 2293-300.
11. Chittal, S. M., Alard, C., Rossi, J. F., al Saati, T., Le Tourneau, A., Diebold, J., et al. (1990). Further phenotypic evidence that nodular, lymphocyte-predominant Hodgkin's disease is a large B-cell lymphoma in evolution. American Journal of Surgical Pathology, 14, 1024-1035.
12. Bennet, M. H., MacLennan, K. A., Vaughan-Hudson, G. and Vaughan-Hudson, B. (1991). Non-Hodgkin's lymphoma arising in patients treated for Hodgkin's disease in the BNLI: a 20-year experience. British National Lymphoma Investigation. Annals of Oncology, 2 (Suppl 2), 83-92.
13. Harris, N. L. (1992). The relationship between Hodgkin's disease and Non-Hodgkin's Lymphoma. Seminars Diagnostic Pathology, 9, 304-10.
14. Jaffe, E. S., Zarate Osorno, A. and Kingma, D. W. (1994). The interrelationship between Hodgkin's disease and non Hodgkin's lymphomas. Annals of Oncology, 5(Suppl 1), S7-11.
15. Schmid, C., Sangent, C. and Isaacson, P. (1991). L and H cells of nodular lymphocyte Hodgkin's disease show immunoglobulin ligh chain restriction. American Journal of Pathology, 139, 1281-89.
16. Momose, H., Chen, Y. Y., Ben-Ezra, J and Weiss, L. M (1992). Nodular lymphocyte-predominant Hodgkin's disease: study of immunoglobulin light chain protein and mRNA expression. Human Pathology, 23, 1115-19.
17. Kuppers, R., Rajewsky, K., Zhao, M., Smons, G., Laumann, R., Fischer, R., et al. (1994). Hodgkin's disease: Hodgkin and Reed Stemberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and apper to be derived from B cells at various stages of development. Proceeding of the National Academy of Science USA, 91, 10962-66.
18. Roth, J., Daus, H., Trumper, L., et al. (1994). Detection of immunoglobulin haevy-chain gene rearrangement at the single cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Stemberg cells. International Journal of Cancer, 57, 799-804
19. Tamaru, J., Hummel, M., Zemlin, M., Kalvelage, B. and Stein, H. (1994). Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the Vh genes. Blood, 84, 708-15.
20. Said, J. V., Sassoon, A F., Shintaku, I. P., Kurtin, P. J. and Pinkus, G. S. A. (1991). Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Souther blot analysis and polymerase chain reaction. American Journal of Pathology, 138, 261-64.
21. Delabie, J., Tierens, A., Wu, G., Weisemburger, D. D. and Chan, W. C. (1994). Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood, 84, 3291-3298.
22. Wickert, R. S., Weisenburger, D. D., Tierens, A., Greiner, T. C. and Chan, W. C. (1995). Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood, 86, 2312-2320.
23. Stoler, M H., Nichols, G E., Symbula, M. and Weiss, L. M. (1995). Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light-chain-restricted monotypic B-cell neoplasm. American Journal of Pathology, 146, 812-18.
24. Pan, L X., Diss, H. C., Peng, H. Z., Norton, A. J. and Iasaacson, P. G. (1996). Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder? Blood, 87, 2428-2434.
25. Lukes, R. J. and Butler, J. J. (1966). The pathology and nomenclature of Hodgkin's disease. Cancer Research, 26, 1063-1081.
26. Carbone, P. P., Kaplan, H. S. and Musshoff, K. (1971). Report of the Committee on Hodgkin's disease staging. Cancer Research, 31, 1860-1861.
27. Kaplan, E. L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of American Statistics Association, 53, 457-81.
28. Hansmann, M. L., Zwinglis, T, Boske, T., Loffler, H. and Lennert, K. (1984). Clinical features of Nodular Paragranuloma (Hodgkin's disease lymphocyte predominant, nodular). Journal of Cancer Research and Clinical Oncology, 108, 321-33.
29. Regula, D. P., Hoppe, R. T. and Weiss, L M. (1988). Nodular and diffuse types of lymphocyte predominance Hodgkin' s disease. New England Journal of Medicine, 318, 214-19.
30. Trudel, M. A., Krikorian, J. G. and Neiman, R. S. (1987). Lymphocyte predominance Hodgkin's disease: A clinicopathologic reassessment. Cancer, 59, 99-106.
31. Borg-Grech, A., Radford, J. A., Crowther, D., Swindell, R. and Harris, M (1989). A comparative study of nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease Journal of Clinical Oncology. 7, 1303-09.
32. Tefferi, A., Zellers, R. A., Banks, P., Therneau, T. M. and Colgan, J. P. (1990). Clinical Correlates of distinct immunophenotypic and histologic subcategories of lymphocyte-predominance Hodgkin's disease. Journal of Clinical Oncology, 8, 1959-1965.
33. Papa, V. I., Norton, A. J., Gupatienta, R. K., Wilson, A. M., Rohatiner, A. Z. S. and Lister, T. A. (1995). Nodular type of lymphocyte prdominance Hodgin's disease. A clinical study of 50 cases, Annals of Oncology, 6, 559-565.
34. Sextro, M., Franklin, J., Hansmann, M. L., Stein, H. and Diehl, V. (1995). Report on the consensus meeting on LP-HD (Cologne; September 1995). Annals of Oncology, 7 (Supplement 3), 7.
35. Herman, T., Hoppe, R., Donaldson, S., et al. (1985). Late relapse among patients treated for Hodgkin's disease Annals of Internal Medicine, 102, 292-97.
36. Bodis, S., Henry-Amar, M., Bosq, J., Burgers, J. M. V., Mellink, W. A. M., Dietrich, P. Y., et al. (1993). Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer Protocols. Journal of Clinical Oncology, 11, 225-32.
37. Poppema, S, Kaiserling, E. and Lennert, K. (1979). Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centers. A cytohistological study. Histopathology, 3, 295-308.
38. Burns, B. F., Colby, T. V. and Dorfman, R. F. (1984). Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. American Journal of Surgical pathology, 8, 253-61.
39. Hansmann, M. L., Shibata, D., Lorenzen, J., Hell, K., Nathwani, B. N and Fischer, R. (1994). Incidence of Ebstem-Barr virus bcl-2 expression and chromosomal translocation t(14;18) in large cell lymphoma associated with paragranuloma (lymphocyte predominant Hodgkin's disease). Human Pathology. 25, 240-43.
40. Falini, B., Bigerna, B., Pasqualucci, L., et al. (1996). Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood, 87, 465-471.
41. Nolte, M., Werner, M., Spann, W., Schnabel, B., von Wasielewski, R., Wilkens, L., et al. (1995). The bcl-2/JH gene rearrangement is undetectable in Hodgkin's Lymphomas: results from the German Hodgkin Trial. Virchows Archives, 426, 37-41.
42. Zarate-Osorno, A., Medeiros, L. J., Longo, D. L. and Jaffe, E. S. (1992). Non-Hodgkin's Lymphomas arising in patients successfully treated for Hodgkin's disease. American Journal of Surgical Pathology, 16, 885-895.
43. Dietrich, P. Y., Henry-Hamar, M., Cosset, J. M., Bodis, S., Bosq, J. and Hyat, M. (1994). Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen? Blood, 84, 1209-1215.
44. Van Leeuwen, F. E., Klokman, W J., Hagenbeek, A., Noyon, R., van der Belt-Dusebout, A. W., van Kerkhoff, E H. M., van Heerde, P. and Somers, R. (1994). Second cancer risk following Hodgkin's disease: a 20-year follow up study. Journal of Clinical Oncology, 12, 312-325.
45. Hansmann, M., Stein, H. and Fellbaum, C. (1989). Nodular paragranuloma can transform into high-grade malignant lymphoma of B type Human Pathology, 20, 1169-75
46. Paulli, M., Rosso, R., Kindl, S., Boveri, E., Sirchi, M., De Medici, A., Invernizzi, R. and Magnni, U. (1992). Nodular sclerosing Hodgkin's disease and large cell lymphoma. Immunophenotypic characterization of a composite case. VirchowsArchiv A Pathological Anatomy and Histophatology, 421, 271-275.
47. Sundeen, J. T., Cossman, J. and Jaffe, E. S. (1988). Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma": histological progression or composite malignancy? American Journal of Surgical Pathology. 12, 599-606.
48. Grossmann, D. M., Hanson, C. A. and Schnitzer, B. (1991). Simultaneous lymphocyte predominant Hodgkin's disease and large cell lymphoma. 7, 15, 668-676.